LEE F. MD PhD ALLEN

This profile gathers the share dealings of LEE F. MD PhD ALLEN across 2 companies, led by Dova Pharmaceuticals Inc. and Argos Therapeutics Inc. The record holds 6 filings, for trades running from 19 January 2017 to 12 November 2019.

On the open market, the record shows 1 purchase worth €52k and 2 sales worth €50k. The net balance comes to €2,711 on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants. In 2019 alone, the filings show no purchases and 2 sales.

Most recently, on 12 November 2019, the filings show a transaction in Dova Pharmaceuticals Inc. The last insider purchase was made public on 7 July 2017, 3,392 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.